{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:26:44Z","timestamp":1784204804085,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001245","name":"Jeffrey Modell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jaip.2025.04.058","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T19:22:18Z","timestamp":1747423338000},"page":"2151-2161.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Skin Manifestations in Adults With Chronic Granulomatous Disease in the United Kingdom"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4315-9105","authenticated-orcid":false,"given":"Luiza C.","family":"Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Arteaga","family":"Henr\u00edquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Meligonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Tadros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Grimbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan O.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine H.","family":"Orteu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.04.058_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","article-title":"Chronic granulomatous disease. Report on a national registry of 368 patients","volume":"79","author":"Winkelstein","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2025.04.058_bib2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00005792-200005000-00004","article-title":"Genetic, biochemical, and clinical features of chronic granulomatous disease","volume":"79","author":"Segal","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2025.04.058_bib3","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaci.2014.04.014","article-title":"Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease","volume":"134","author":"Magnani","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.04.058_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2249.2008.03644.x","article-title":"Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry","volume":"152","author":"Jones","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2025.04.058_bib5","first-page":"1","article-title":"Long-term outcomes for adults with chronic granulomatous disease in the United Kingdom","volume":"11","author":"Campos","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.04.058_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.hoc.2012.11.002","article-title":"Chronic granulomatous disease","volume":"27","author":"Holland","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jaip.2025.04.058_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12016-009-8136-z","article-title":"Chronic granulomatous disease","volume":"38","author":"Holland","year":"2010","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaip.2025.04.058_bib8","series-title":"Cutaneous Crohn Disease. Treasure Island, Fl","author":"Bernett","year":"2025"},{"key":"10.1016\/j.jaip.2025.04.058_bib9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2025.04.058_bib10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/cid\/ciw837","article-title":"Chronic granulomatous disease in patients reaching adulthood: a nationwide study in France","volume":"64","author":"Dunogu\u00e9","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2025.04.058_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clim.2007.09.008","article-title":"Clinical features, long-term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study","volume":"126","author":"Martire","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2025.04.058_bib12","series-title":"chapter 40","article-title":"Rook\u2019s Textbook of Dermatology","author":"Wakelin","year":"2024"},{"key":"10.1016\/j.jaip.2025.04.058_bib13","first-page":"420","article-title":"Demodex mites modulate sebocyte immune reaction: possible role in the pathogenesis of rosacea","volume":"179","author":"Lacey","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.04.058_bib14","author":"Ballard"},{"key":"10.1016\/j.jaip.2025.04.058_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10875-020-00901-8","article-title":"Infections in patients with chronic granulomatous disease treated with tumor necrosis factor alpha blockers for inflammatory complications","volume":"41","author":"Conrad","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2025.04.058_bib16","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/rheumatology\/keac358","article-title":"Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries","volume":"62","author":"Glintborg","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaip.2025.04.058_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2249.2007.03321.x","article-title":"Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology","volume":"148","author":"Cale","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2025.04.058_bib18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1365-2133.1981.tb08163.x","article-title":"Discoid lupus erythematosus\u2013like lesions in fenale carriers of X-linked chronic granulomatous disease","volume":"104","author":"Brandrup","year":"1981","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.04.058_bib19","first-page":"452","article-title":"Lupus erythematosus and chronic granulomatous disease: report of four Iranian patients with AR-CGD and one XL-CGD","volume":"18","author":"Maddah","year":"2019","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2025.04.058_bib20","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1111\/pde.12826","article-title":"Association between discoid lupus erythematosus and chronic granulomatous disease\u2014report of two cases and review of the literature","volume":"33","author":"Xie","year":"2016","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaip.2025.04.058_bib21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/rheumatology\/kei135","article-title":"Abnormal apoptosis in chronic granulomatous disease and autoantibody production characteristic of lupus","volume":"45","author":"Sanford","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaip.2025.04.058_bib22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/cea.13784","article-title":"The epidemiology of eczema in children and adults in England: a population-based study using primary care data","volume":"51","author":"de Lusignan","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.04.058_bib23","first-page":"282","article-title":"Incidence and prevalence of rosacea: a systematic review and meta-analysis","volume":"179","author":"Gether","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.04.058_bib24","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood.2020005590","article-title":"Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults","volume":"136","author":"Chiesa","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2025.04.058_bib25","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s13555-021-00562-4","article-title":"Acne scarring: why we should act sooner rather than later","volume":"11","author":"Dr\u00e9no","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jaip.2025.04.058_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2022.0416","article-title":"Management of orofacial granulomatosis","volume":"29","author":"Joshi","year":"2023","journal-title":"Br J Hosp Med (Lond)"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825004842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825004842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:57:06Z","timestamp":1778853426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219825004842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2213219825004842"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.04.058","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin Manifestations in Adults With Chronic Granulomatous Disease in the United Kingdom","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.04.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}